Global DNA methylation status in laryngeal cancer

Head and Neck

Volumn 36, Issue 3, 2014, Pages 419-424

  Stembalska, Agnieszka ^a   Leszczyński, Przemysław ^a   Gil, Justyna ^a   Ramsey, David ^b   Pitala, Grzegorz ^c   Maciejczyk, Adam ^d   Fra̧czek, Marcin ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF LIMERICK   (Ireland)

^c 4TH MILITARY HOSPITAL   (Poland)

^d Wroclaw   (Poland)

Author keywords

5 methylcytosine; DNA hypomethylation; epigenetics; laryngeal cancer; ultra performance liquid chromatography

Indexed keywords

5-METHYLCYTOSINE; DNA HYPOMETHYLATION; EPIGENETICS; LARYNGEAL CANCER; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

5-METHYLCYTOSINE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DNA METHYLATION; EPIGENOMICS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED;

EID: 84894264826     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23315     Document Type: Article

References (60)

1. Crowe DL, Hacia JG, Hsieh CL, Sinha UK, Rice H,. Molecular pathology of head and neck cancer. Histol Histopathol 2002; 17: 909-914.
2. Demokan S, Dalay N,. Role of DNA methylation in head and neck cancer. Clin Epigenetics 2011; 2: 123-150.
3. Martínez JG, Pérez-Escuredo J, Castro-Santos P, et al. Hypomethylation of LINE-1, and not centromeric SAT-α, is associated with centromeric instability in head and neck squamous cell carcinoma. Cell Oncol (Dordr) 2012; 35: 259-267.
4. Wang J, Chen H, Fu S, Xu ZM, Sun KL, Fu WN,. The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinoma. Oral Oncol 2011; 47: 601-608.
5. European Union International Agency for Research. Available at: http://eu-cancer.iarc.fr. Accessed February 28, 2013.
6. Marioni G,. Letter to the editors: Essentials for an updated epidemiology of laryngeal carcinoma. Cancer Treat Rev. 2012; 38: 559.
7. http://onkologia.org.pl
8. Al-Kayed S, Qasem MB,. Laryngeal cancer. Chapter 7. In:, Freedman LS, Edwards BK, Ries LAG, Young JL, editors. Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER. National Cancer Institute, 2006. NIH Pub. No. 06-5873. Bethesda, MD. Available at: http://mecc.cancer.gov/ publication/mecc-monograph.pdf. Accessed February 28, 2013.
9. Pelucchi C, Tramacere I, Boffetta P, Negri E, La Vecchia C,. Alcohol consumption and cancer risk. Nutr Cancer 2011; 63: 983-990.
10. Sinha P, Logan HL, Mendenhall WM,. Human papillomavirus, smoking, and head and neck cancer. Am J Otolaryngol. 2012; 33: 130-136.
11. Das PM, Singal R,. DNA methylation and cancer. J Clin Oncol 2004; 22: 4632-4642.
12. Daura-Oller E, Cabre M, Montero MA, Paternain JL, Romeu A,. Specific gene methylation and cancer: new insights into coding region features trends. Bioinformation 2009; 3: 340-343.
13. De Smet C, Loriot A,. DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey. Epigenetics 2010 [Epub ahead of print].
14. Ehrlich M,. DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21: 5400-5413.
15. Hoffmann MJ, Schulz WA,. Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol 2005; 83: 296-321.
16. Poage GM, Houseman EA, Christensen BC, et al. Global hypomethylation identifies loci targeted for hypermethylation in head and neck cancer. Clin Cancer Res 2011; 17: 3579-3589.
17. Jintaridth P, Mutirangura A,. Distinctive patterns of age-dependent hypomethylation in interspersed repetitive sequences. Physiol Genomics 2010; 41: 194-200.
18. McCabe DC, Caudill MA,. DNA methylation, genomic silencing, and links to nutrition and cancer. Nutr Rev 2005; 6: 183-195.
19. Pogribny IP,. Epigenetic events in tumorigenesis: putting the pieces together. Exp Oncol 2010; 32: 132-136.
20. Steinhoff C, Schulz WA,. Transcriptional regulation of the human LINE-1 retrotransposon L1.2B. Mol Genet Genomics 2003; 270: 394-402.
21. Stach D, Schmitz OJ, Stilgenbauer S, et al. Capillary electrophoretic analysis of genomic DNA methylation levels. Nucleic Acids Res 2003; 31: E2.
22. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787-793.
23. Smith IM, Mydlarz WK, Mithani SK, Califano JA,. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer 2007; 121: 1724-1728.
24. Yang AS, Estécio MR, Doshi K, Kondo Y, Tajara EH, Issa JP,. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32: e38.
25. Kaneda A, Tsukamoto T, Takamura-Enya T, et al. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci 2004; 95: 58-64.
26. Choi JY, James SR, Link PA, et al. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 2009; 30: 1889-1897.
27. Furniss CS, Marsit CJ, Houseman EA, Eddy K, Kelsey KT,. Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 2008; 17: 966-971.
28. Taby R, Issa JP,. Cancer epigenetics. CA Cancer J Clin 2010; 60: 376-392.
29. Zhu ZZ, Sparrow D, Hou L, et al. Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study. Cancer Causes Control 2011; 22: 437-447.
30. Woo HD, Kim J,. Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS One 2012; 7: e34615.
31. Cho YH, Yazici H, Wu HC, et al. Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. Anticancer Res 2010; 30: 2489-2496.
32. Hsiung DT, Marsit CJ, Houseman EA, et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 108-114.
33. Moore LE, Pfeiffer RM, Poscablo C, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 2008; 9: 359-366.
34. Pufulete M, Al-Ghnaniem R, Leather AJ, et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003; 124: 1240-1248.
35. Wu HC, Wang Q, Yang HI, Tsai WY, Chen CJ, Santella RM,. Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study. Carcinogenesis 2012; 33: 1340-1345.
36. Coney CA, Wise CK, Poirier LA,. An improved sample preparation method for the quantitative HPLC determination of 5-methyl-deoxycytidine in animal tissue DNA. J Liq Chromatogr Relat Technol 1997; 20: 1279-1293.
37. Fuke C, Shimabukuro M, Petronis A, et al. Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet 2004; 68 (Pt 3): 196-204.
38. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005; 102: 10604-10609.
39. Suzuki K, Suzuki I, Leodolter A, et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 2006; 9: 199-207.
40. Dong SM, Sun DI, Benoit NE, Kuzmin I, Lerman MI, Sidransky D,. Epigenetic inactivation of RASSF1A in head and neck cancer. Clin Cancer Res 2003; 9 (10 Pt 1): 3635-3640.
41. Eden A, Gaudet F, Waghmare A, Jaenisch R,. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300: 455.
42. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT,. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 2002; 21: 4231-4236.
43. Smiraglia DJ, Smith LT, Lang JC, et al. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet 2003; 40: 25-33.
44. Cravo M, Fidalgo P, Pereira AD, et al. DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur J Cancer Prev 1994; 3: 473-479.
45. Figueiredo JC, Grau MV, Wallace K, et al. Global DNA methylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 2009; 18: 1041-1049.
46. Costello JF, Plass C,. Methylation matters. J Med Genet 2001; 38: 285-303.
47. Szpakowski S, Sun X, Lage JM, et al. Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements. Gene 2009; 448: 151-167.
48. Jackson K, Yu MC, Arakawa K, et al. DNA hypomethylation is prevalent even in low-grade breast cancers. Cancer Biol Ther 2004; 3: 1225-1231.
49. Stembalska A,. Loss of heterozygosity of chosen genes and genetic instability in laryngeal squamous cell carcinoma. [PhD thesis, in Polish]. Wroclaw, 2002, unpublished data.
50. Narayan A, Ji W, Zhang XY, et al. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 1998; 77: 833-838.
51. Hermsen MA, Joenje H, Arwert F, et al. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Genes Chromosomes Cancer 1996; 15: 1-9.
52. Jin C, Jin Y, Wennerberg J, Dictor M, Mertens F,. Nonrandom pattern of cytogenetic abnormalities in squamous cell carcinoma of the larynx. Genes Chromosomes Cancer 2000; 28: 66-76.
53. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH,. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-1730.
54. Gabriel HE, Crott JW, Ghandour H, et al. Chronic cigarette smoking is associated with diminished folate status, altered folate from distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr 2006; 83: 835-841.
55. Pufulete M, Al-Ghnaniem R, Khushal A, et al. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 2005; 54: 648-653.
56. Shahrzad S, Bertrand K, Minhas K, Coomber BL,. Induction of DNA hypomethylation by tumor hypoxia. Epigenetics 2007; 2: 119-125.
57. Sapkota A, Hsu CC, Zaridze D, et al. Dietary risk factors for squamous cell carcinoma of the upper aerodigestive tract in central and eastern Europe. Cancer Causes Control 2008; 19: 1161-1170.
58. Kruszyna Ł, Lianeri M, Rydzanicz M, Gajecka M, Szyfter K, Jagodziński PP,. Polymorphic variants of folate metabolism genes and the risk of laryngeal cancer. Mol Biol Rep 2010; 37: 241-247.
59. Paz MF, Avila S, Fraga MF, et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 2002; 62: 4519-4524.
60. Piyathilake CJ, Bell WC, Jones J, et al. Pattern of nonspecific (or global) DNA methylation in oral carcinogenesis. Head Neck 2005; 27: 1061-1067.